Adaptive Biotechnologies (ADPT) Stock Price

$8.27 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    2

  • Technical

    8

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Adaptive Biotechnologies, AI stock picks, stock alerts and much more.

Sign up

ADPT AI Stock Analysis

AI stock analysis for ADPT is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Adaptive Biotechnologies (ADPT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Adaptive Biotechnologies (ADPT) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Adaptive Biotechnologies (ADPT), currently trading at $8.27, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ADPT

LSE

  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

  • Symbol

    ADPT

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.2B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
February 12, 2025. zacks.com
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
February 5, 2025. globenewswire.com
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
January 17, 2025. zacks.com
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
January 16, 2025. zacks.com

ADPT Alternative Data

Web Traffic

Adaptive Biotechnologies receives an estimated 33226 monthly visitors to adaptivebiotech.com.

  • Web Traffic

    33226

  • Change from Previous Month

    26.6%

  • 3 Month Change

    64.6%

  • YoY Change

    64.6%

News Mentions

Adaptive Biotechnologies was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Reddit Mentions

Adaptive Biotechnologies has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Twitter Followers

Adaptive Biotechnologies has 4,604 Twitter Followers on its main Twitter (also known as X) account, which is down by -1.1% over the last month.

  • Twitter Followers

    4604

  • Daily Change

    0.1%

  • 1 Month Change

    1.1%

  • 3 Month Change

    2%

  • YoY Change

    2%

Facebook Engagement

Adaptive Biotechnologies has engaged 3 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    3

  • Daily Change

    50%

  • 1 Month Change

    0%

  • 3 Month Change

    95%

  • YoY Change

    95%

Instagram Followers

Adaptive Biotechnologies has 1,212 Instagram Followers on its main Instagram account, up by 0.3% over the last month.

  • Instagram Followers

    1212

  • Daily Change

    0.1%

  • 1 Month Change

    0.3%

  • 3 Month Change

    0.7%

  • YoY Change

    0.7%

LinkedIn Followers

29,970 are following Adaptive Biotechnologies on LinkedIn, up by 0.7% over the last month.

  • LinkedIn Followers

    29970

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    1.8%

Job Postings

Adaptive Biotechnologies has an estimated 14 open job postings, which is down -12.5% over the last month.

  • Job Postings

    14

  • Daily Change

    7.7%

  • 1 Month Change

    12.5%

  • 3 Month Change

    22.2%

  • YoY Change

    22.2%

LinkedIn Employees

According to LinkedIn, Adaptive Biotechnologies has 657 employees, down by -1.8% over the last month.

  • LinkedIn Employees

    657

  • Daily Change

    0%

  • 1 Month Change

    1.8%

  • 3 Month Change

    1.5%

  • YoY Change

    1.5%

Business Outlook

  • Business Outlook

    28

  • Change from Previous Month

    40%

  • 3 Month Change

    0%

  • YoY Change

    0%

ADPT Financials

ADPT Key Metrics

  • Total Revenue

    $46.4M

  • Net Income

    -$32.1M

  • Earnings per Share

    -$0.22

  • Free cash flow

    -$27.4M

  • EBITDA

    -$24.6M

  • EBITDA Ratio

    -0.529062

  • Total Assets

    $558.5M

ADPT 2-year Revenue & Income
ADPT 2-year Free Cash Flow

ADPT Technicals

ADPT SMA
ADPT RSI

FAQ

What's the current price of Adaptive Biotechnologies (ADPT) Stock?
The price of an Adaptive Biotechnologies (ADPT) share is $8.27.

What's the market cap of Adaptive Biotechnologies?
The current market cap of Adaptive Biotechnologies is 1.2B.

Should I buy or sell ADPT?
Adaptive Biotechnologies shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Adaptive Biotechnologies is better viewed as a hold or accumulate position while waiting for further developments.

Is Adaptive Biotechnologies a good investment?
The current analysis of Adaptive Biotechnologies' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Adaptive Biotechnologies' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Adaptive Biotechnologies (ADPT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Adaptive Biotechnologies stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Adaptive Biotechnologies (ADPT) that investors often compare it to?
Adaptive Biotechnologies (ADPT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Adaptive Biotechnologies' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Adaptive Biotechnologies' stock price to be around $8.21 in 2026. Starting from the current price of $8.27, this represents a 0.7% change in price, indicating a neutral outlook for the stock.

How to buy Adaptive Biotechnologies (ADPT) Stock?
Adaptive Biotechnologies stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Adaptive Biotechnologies shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.